Combined deletion of cathepsin protease family members reveals compensatory mechanisms in cancer

Genes and Development

Volumn 30, Issue 2, 2016, Pages 220-232

  Akkari, Leila ^a,b   Gocheva, Vasilena ^a   Quick, Marsha L ^a   Kester, Jemila C ^a   Spencer, Alison K ^a   Garfall, Alfred L ^a   Bowman, Robert L ^a   Joyce, Johanna A ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Invasion; Macrophage; Tumor microenvironment

Indexed keywords

CATHEPSIN; PROTEINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE DELETION; GENOTYPE; MOUSE; NEOPLASM; NONHUMAN; PANCREATIC NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; PROTEIN FAMILY; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR MICROENVIRONMENT; ANIMAL; APOPTOSIS; C57BL MOUSE; CARCINOMA; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; MACROPHAGE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS TUMOR; PATHOPHYSIOLOGY;

ANIMALS; APOPTOSIS; CARCINOGENESIS; CARCINOMA, NEUROENDOCRINE; CATHEPSINS; DISEASE MODELS, ANIMAL; GENE DELETION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; MACROPHAGES; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS;

EID: 84954506618     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.270439.115     Document Type: Article

References (56)

1. Affara NI, Andreu P, Coussens LM. 2009. Delineating protease functions during cancer development. Methods Mol Biol 539: 1-32.
2. Akkari L, Gocheva V, Kester JC, Hunter KE, Quick ML, Sevenich L, Wang HW, Peters C, Tang LH, Klimstra DS, et al. 2014. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix. Genes Dev 28: 2134-2150.
3. auf dem Keller U, Doucet A, Overall CM. 2007. Protease research in the era of systems biology. Biol Chem 388: 1159-1162.
4. Ben-Baruch A. 2006. The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev 25: 357-371.
5. Benavides F, Perez C, Blando J, Contreras O, Shen J, Coussens LM, Fischer SM, Kusewitt DF, DiGiovanni J, Conti CJ. 2012. Protective role of cathepsin L in mouse skin carcinogenesis. Mol Carcinog 51: 352-361.
6. Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF. 1994. Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene 139: 163-169.
7. Coussens LM, Fingleton B, Matrisian LM. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
8. Dennemarker J, Lohmuller T, Mayerle J, Tacke M, Lerch MM, Coussens LM, Peters C, Reinheckel T. 2010. Deficiency for the cysteine protease cathepsin L promotes tumor progression in mouse epidermis. Oncogene 29: 1611-1621.
9. Deussing J, von Olshausen I, Peters C. 2000. Murine and human cathepsin Z: cDNA-cloning, characterization of the genes and chromosomal localization. Biochim Biophys Acta 1491: 93-106.
10. Dufour A, Overall CM. 2013. Missing the target: matrix metallo-proteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 34: 233-242.
11. Elie BT, Gocheva V, Shree T, Dalrymple SA, Holsinger LJ, Joyce JA. 2010. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model. Biochimie 92: 1618-1624.
12. Fortelny N, Cox JH, Kappelhoff R, Starr AE, Lange PF, Pavlidis P, Overall CM. 2014. Network analyses reveal pervasive functional regulation between proteases in the human protease web. PLoS Biol 12: e1001869.
13. Gocheva V, Joyce JA. 2007. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6: 60-64.
14. Gocheva V, Zeng W, Ke D, Klimstra D, Reinheckel T, Peters C, Hanahan D, Joyce JA. 2006. Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev 20: 543-556.
15. Gocheva V, Chen X, Peters C, Reinheckel T, Joyce JA. 2010a. Deletion of cathepsin H perturbs angiogenic switching, vascularization and growth of tumors in a mouse model of pancreatic islet cell cancer. Biol Chem 391: 937-945.
16. Gocheva V, Wang HW, Gadea BB, Shree T, Hunter KE, Garfall AL, Berman T, Joyce JA. 2010b. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev 24: 241-255.
17. Gopinathan A, Denicola GM, Frese KK, Cook N, Karreth FA, Mayerle J, Lerch MM, Reinheckel T, Tuveson DA. 2012. Cathepsin B promotes the progression of pancreatic ductal ade-nocarcinoma in mice. Gut 61: 877-884.
18. Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR. 2008. ‘Reeducating’ tumor-associated macrophages by targeting NF-κB. J Exp Med 205: 1261-1268.
19. Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthen-buerger M, Reinheckel T, Domschke W, Lippert H, Peters C, Deussing J. 2000. Role of cathepsin B in intracellular trypsin-ogen activation and the onset of acute pancreatitis. J Clin In-vest 106: 773-781.
20. Hamilton JA. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 8: 533-544.
21. Hanahan D. 1985. Heritable formation of pancreatic β-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315: 115-122
22. Jedeszko C, Sloane BF. 2004. Cysteine cathepsins in human cancer. Biol Chem 385: 1017-1027.
23. Joyce JA, Baruch A, Chehade K, Meyer-Morse N, Giraudo E, Tsai FY, Greenbaum DC, Hager JH, Bogyo M, Hanahan D. 2004. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5: 443-453.
24. Karin M. 2006. Nuclear factor-κB in cancer development and progression. Nature 441: 431-436.
25. Karin M, Greten FR. 2005. NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
26. Kessenbrock K, Wang CY, Werb Z. 2015. Matrix metalloproteinases in stem cell regulation and cancer. Matrix Biol 44-46C: 184-190.
27. Lopez T, Hanahan D. 2002. Elevated levels of IGF-1 receptor con-vey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell 1: 339-353
28. Lopez-Otin C, Bond JS. 2008. Proteases: multifunctional enzymes in life and disease. J Biol Chem 283: 30433-30437
29. Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R. 2010. The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 21: 27-39.
30. Mason SD, Joyce JA. 2011. Proteolytic networks in cancer. Trends Cell Biol 21: 228-237.
31. McCullagh P. 1980. Regression models for ordinal data. J R Stat Soc 42: 109-142.
32. Mohamed MM, Sloane BF. 2006. Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6: 764-775.
33. Nagler DK, Menard R. 1998. Human cathepsin X: a novel cysteine protease of the papain family with a very short proregion and unique insertions. FEBS Lett 434: 135-139.
34. Nagler DK, Zhang R, Tam W, Sulea T, Purisima EO, Menard R. 1999. Human cathepsin X: a cysteine protease with unique carboxypeptidase activity. Biochemistry 38: 12648-12654
35. Okabe M, Ikawa M, Kominami K, Nakanishi T, Nishimune Y. 1997. ‘Green mice’ as a source of ubiquitous green cells. FEBS Lett 407: 313-319.
36. Olson OC, Joyce JA. 2015. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat Rev Cancer 15: 712-729.
37. Pachkov M, Erb I, Molina N, van Nimwegen E. 2007. Swiss Regulon: a database of genome-wide annotations of regulatory sites. Nucleic Acids Res 35: D127-D131.
38. Parangi S, Dietrich W, Christofori G, Lander ES, Hanahan D. 1995. Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Res 55: 6071-6076.
39. Pyonteck SM, Gadea BB, Wang HW, Gocheva V, Hunter KE, Tang LH, Joyce JA. 2012. Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development. Oncogene 31: 1459-1467.
40. Qian BZ, Pollard JW. 2010. Macrophage diversity enhances tumor progression and metastasis. Cell 141: 39-51.
41. Quail DF, Joyce JA. 2013. Microenvironmental regulation of tumor progression and metastasis. Nat Med 19: 1423-1437.
42. Robinson SC, Scott KA, Wilson JL, Thompson RG, Proudfoot AE, Balkwill FR. 2003. A chemokine receptor antagonist in-hibits experimental breast tumor growth. Cancer Res 63: 8360-8365.
43. Ruffell B, Affara NI, Cottone L, Junankar S, Johansson M, DeNardo DG, Korets L, Reinheckel T, Sloane BF, Bogyo M, et al. 2013. Cathepsin C is a tissue-specific regulator of squamous carcinogenesis. Genes Dev 27: 2086-2098.
44. Santamaria I, Velasco G, Pendas AM, Fueyo A, Lopez-Otin C. 1998. Cathepsin Z, a novel human cysteine proteinase with a short propeptide domain and a unique chromosomal loca-tion. J Biol Chem 273: 16816-16823.
45. Sevenich L, Joyce JA. 2014. Pericellular proteolysis in cancer. Genes Dev 28: 2331-2347.
46. Sevenich L, Schurigt U, Sachse K, Gajda M, Werner F, Muller S, Vasiljeva O, Schwinde A, Klemm N, Deussing J, et al. 2010. Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci 107: 2497-2502.
47. Shchors K, Nozawa H, Xu J, Rostker F, Swigart-Brown L, Evan G, Hanahan D. 2013. Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigene-sis. Oncogene 32: 502-513.
48. Shi GP, Munger JS, Meara JP, Rich DH, Chapman HA. 1992. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. J Biol Chem 267: 7258-7262.
49. Shi GP, Villadangos JA, Dranoff G, Small C, Gu L, Haley KJ, Riese R, Ploegh HL, Chapman HA. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center de-velopment. Immunity 10: 197-206.
50. Soria-Valles C, Gutierrez-Fernandez A, Guiu M, Mari B, Fueyo A, Gomis RR, Lopez-Otin C. 2014. The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene 33: 3054-3063.
51. Turk V, Stoka V, Vasiljeva O, Renko M, Sun T, Turk B, Turk D. 2012. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochim Biophys Acta 1824: 68-88
52. Vasiljeva O, Papazoglou A, Kruger A, Brodoefel H, Korovin M, Deussing J, Augustin N, Nielsen BS, Almholt K, Bogyo M, et al. 2006. Tumor cell-derived and macrophage-derived ca-thepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res 66: 5242-5250.
53. Vasiljeva O, Korovin M, Gajda M, Brodoefel H, Bojic L, Kruger A, Schurigt U, Sevenich L, Turk B, Peters C, et al. 2008. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene 27: 4191-4199.
54. Wang HW, Joyce JA. 2010. Alternative activation of tumor-associated macrophages by IL-4: priming for protumoral functions. Cell Cycle 9: 4824-4835.
55. Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kal-luri R, Shi GP. 2006. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 281: 6020-6029.
56. Yin T, Cook D, Lawrence M. 2012. ggbio: an R package for extending the grammar of graphics for genomic data. Genome Biol 13: R77.